Cellartis and WARF Sign License Agreement for Human Embryonic Stem Cells
News Jan 19, 2009
Cellartis AB and the Wisconsin Alumni Research Foundation (WARF), the private, nonprofit patenting and licensing organization for the University of Wisconsin-Madison, announced that they have signed a license for hES patents which enables Cellartis to commercialize undifferentiated hES cell products in the US.
"This is another significant and timely step forward for Cellartis and we are delighted to make this announcement," said Mats Lundwall, CEO.
"Our business is at an exciting point in its evolution as we broaden our range of products and drive growth through innovative collaborations. This license opens the door to the large and important US market, alongside additional emerging partnering opportunities in the US which fits well into our growth strategy,” Lundwall added.
"We are extremely pleased to announce our licensing agreement and welcome Cellartis as a new commercial partner," says Andy DeTienne, WARF's licensing manager for stem cell technologies.
"As a key provider of human embryonic stem cells and related products, we are pleased Cellartis is interested in entering the U.S. market. The expansion of Cellartis’ business strategy complements WARF’s goals for supporting growth in the human stem cell industry." He notes this licensing agreement with Cellartis reflects that commercial interest in human embryonic stem cells continues to be strong.
Switch Discovered to Convert Blood Vessels to Blood Stem Cells During Embryonic DevelopmentNews
Findings could aid research into creating new blood cells for transplants and understanding cancer metastasis.READ MORE
Unraveling How Mesenchymal Stem Cells From Gum Tissue Accelerate Wound HealingNews
To assist with wound healing, mesenchymal stem cells from the gum tissue secrete extracellular vesicles that contain the anti-inflammatory signaling molecule IL-1RA.READ MORE
Mending Broken Hearts with Cardiomyocyte MoldsNews
A team of researchers at Michigan Technological University in collaboration with Harvard Medical School, shows how cardiomyocytes grown in a heart-like environment mature more quickly, have improved functionality and are less likely to be rejected by patients’ bodies.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018
International Conference on Molecular Biology and Stem Cells
Aug 13 - Aug 15, 2018
World Congress on Plant Science and Molecular Biology
Sep 12 - Sep 13, 2018